[Treatment of progressive chronic polyarthritis with a new cytostatic agent, Imet 3393].
D000328:Adult; D000368:Aged; D000596:Amino Acids / Q000037:antagonists & inhibitors; D000970:Antineoplastic Agents / Q000009:adverse effects / Q000627:therapeutic use*; D001172:Arthritis, Rheumatoid / Q000188:drug therapy*; D001562:Benzimidazoles / Q000009:adverse effects / Q000627:therapeutic use*; D006801:Humans; D008875:Middle Aged; D011687:Purines / Q000037:antagonists & inhibitors; D014717:Vertigo / Q000139:chemically induced
D000596:Amino Acids; D000970:Antineoplastic Agents; D001562:Benzimidazoles; D011687:Purines
Behandlung der progressiv-chronischen Polyarthritis mit dem neuen Zytostatikum Imet 3393.